Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Dexamethasone × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 16 Other hematologic neoplasm 2 Lymphoid 2 Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 20 Pemetrexed 19 Cisplatin 17 Paclitaxel 9 pembrolizumab 8 Gemcitabine 7 osimertinib 6 durvalumab 5 Nivolumab 5 Crizotinib 5 atezolizumab 4 Ipilimumab 4 tremelimumab 3 amivantamab 3 Gefitinib 3 Etoposide 3 Docetaxel 3 Albumin-Bound Paclitaxel 3 Afatinib 3 trastuzumab deruxtecan 2 selpercatinib 2 lorlatinib 2 lazertinib 2 cemiplimab 2 PM 01183 2 Erlotinib Hydrochloride 2 130-nm albumin-bound paclitaxel 2 zenocutuzumab 1 trametinib 1 tepotinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02578680 2024-09-20

MK-3475-189

Merck Sharp & Dohme LLC

Phase 3 Completed

616 enrolled 19 charts 1 FDA

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡